News Image

INmune Bio Inc. Announces Publication in Cell Reports Demonstrating XPro™ Promotes Remyelination

Provided By GlobeNewswire

Last update: Oct 24, 2024

Data from Animal Model Study Demonstrate XPro™ converts microglia from a demyelinating cell to a remyelinating cell

Multi-year study published has implications for many CNS diseases including Alzheimer’s

Read more at globenewswire.com

INMUNE BIO INC

NASDAQ:INMB (2/21/2025, 8:00:01 PM)

After market: 8.59 0 (0%)

8.59

-0.5 (-5.5%)



Find more stocks in the Stock Screener

Follow ChartMill for more